Skip to main content
. 2022 Mar 3;12:794034. doi: 10.3389/fonc.2022.794034

Figure 7.

Figure 7

Functional GSEA analysis of PRlncSig and model comparisons. (A) Representative KEGG pathways significantly enriched in high-risk patients. (B) Immune-related signatures significantly enriched in high-risk patients. (C) ROC analysis of the prediction of 3-year survival by PRlncSig and four other signatures.